Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs
about
Discovery and Development of Calcium Channel Blockers.Structural Insights into the Atomistic Mechanisms of Action of Small Molecule Inhibitors Targeting the KCa3.1 Channel Pore.Calcium isotope fractionation between aqueous compounds relevant to low-temperature geochemistry, biology and medicine.K2P2.1 (TREK-1)-activator complexes reveal a cryptic selectivity filter binding site.Development of Safe Drugs: The hERG Challenge.Interpreting the functional role of a novel interaction motif in prokaryotic sodium channels.On the structure and mechanism of two-pore channels.CaV1.3 L-type Ca2+ channel contributes to the heartbeat by generating a dihydropyridine-sensitive persistent Na+ current.Isolated pores dissected from human two-pore channel 2 are functional.Calcium channel structures come of age.LUCS (Light-Up Cell System), a universal high throughput assay for homeostasis evaluation in live cells.Structural Models of Ligand-Bound Sodium Channels.Inherited Ventricular Arrhythmias: The Role of the Multi-Subunit Structure of the L-Type Calcium Channel Complex.The regulatory mechanism of mammalian TRPMLs revealed by cryo-EM.Ionic Coulomb blockade and anomalous mole fraction effect in the NaChBac bacterial ion channel and its charge-varied mutantsVoltage-gated calcium channels: their discovery, function and importance as drug targetsA hypothetical molecular mechanism for TRPV1 activation that invokes rotation of an S6 asparagine
P2860
Q33734936-AAE0F2BD-1809-4DF3-80B9-DA7363D9133CQ36261948-61B0E810-6832-4CFE-8987-9561D38C6B26Q37690375-5ACA6BB9-E2A1-4C99-8C25-05E7FEF9C160Q38686094-ED46B510-1F41-4E91-82C4-32E3F5AE1106Q39280559-0FF8899C-7176-4487-9C7B-6C064EAB6DA8Q39316634-8D018526-D3AF-42A4-8A97-43C3EBBB45BEQ39401923-49A73E3C-422B-4343-8301-05F10787967AQ41367595-15B4AECC-47F7-4503-A13A-AB3C5D1B039FQ42354590-6D55AD91-DD80-469E-8BFD-1C001F7244D1Q47135108-225C00C7-DE36-4F60-8EFE-3E86AFC3831EQ47150433-82A71D5C-12BC-4433-BB13-568357FC9B32Q47236925-E54D2DDF-3FBF-4B70-953D-F06C967D7B5AQ51094903-1C187812-8B1A-458E-9E3F-9BD56B141D3DQ52632031-08907E30-4BD6-4D2F-B4BA-15B678471961Q56534811-DF1A2140-FFF5-4757-AC65-A2E6B47B47A5Q57484915-471DD473-B994-44DA-A454-3A7A1897EB11Q58610880-0B81E805-BDBB-4C8C-9DEE-FFF2AF0F5C4B
P2860
Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs
@ast
Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs
@en
Structural basis for inhibitio ...... <sup>2+</sup> antagonist drugs
@nl
type
label
Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs
@ast
Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs
@en
Structural basis for inhibitio ...... <sup>2+</sup> antagonist drugs
@nl
prefLabel
Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs
@ast
Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs
@en
Structural basis for inhibitio ...... <sup>2+</sup> antagonist drugs
@nl
P2093
P2860
P356
P1433
P1476
Structural basis for inhibitio ...... +</sup> antagonist drugs
@en
P2093
David C Pryde
Ning Zheng
Tamer M Gamal El-Din
Teresa M Swanson
Todd Scheuer
William A Catterall
P2860
P2888
P304
P356
10.1038/NATURE19102
P407
P577
2016-08-24T00:00:00Z
P6179
1053323659